Outpatient medical abortion is safe and effective through 70 days gestation

被引:32
作者
Abbas, Dina [1 ]
Chong, Erica [1 ]
Raymond, Elizabeth G. [1 ]
机构
[1] Gynu Hlth Projects, New York, NY 10010 USA
关键词
UNITED-STATES; MIFEPRISTONE; MISOPROSTOL; TERMINATION; PREGNANCY; REGIMEN;
D O I
10.1016/j.contraception.2015.06.018
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Data show that an outpatient regimen of 200-mg mifepristone followed by a single dose of misoprostol is safe and effective for medical abortion for up to 70 days from last menstrual period (LMP). Yet, many clinics only provide services up to 63 days LMP, and some practice guidelines do not recommend the higher gestational age limit. We review the studies published to date that include women 64 to 70 days LMP and conclude that outpatient medical abortion is safe and effective in this interval and that there are no clinically meaningful differences between outcomes at 57 to 63 days LMP and 64 to 70 days LMP. Updating clinical protocols and revising the Food and Drug administration label for Mifeprex (R) to change the indication for termination of pregnancies through 70 days LMP will give women more choices and expand access to safe abortion services. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:197 / 199
页数:3
相关论文
共 50 条
[21]   Comparison of vaginal and buccal misoprostol after mifepristone for medication abortion through 70 days of gestation: A retrospective chart review [J].
Young, Danielle ;
Fitzgerald, Kelly ;
Laursen, Laura ;
Whitaker, Amy K. .
CONTRACEPTION, 2022, 115 :62-66
[22]   Outcomes of medical abortion through 63 days in women with twin gestations [J].
Hayes, Jennifer L. ;
Achilles, Sharon L. ;
Creinin, Mitchell D. ;
Reeves, Matthew F. .
CONTRACEPTION, 2011, 84 (05) :505-507
[23]   Consistency of medical abortion efficacy from 5 through 14 weeks' gestation [J].
Garbin, Olivier ;
Vayssiere, Christophe ;
Bettahar-Lebugle, Karima ;
Nisand, Israel .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2006, 129 (01) :36-40
[24]   Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curacao [J].
Boersma, Adriana A. ;
Jong, Betty Meyboom-de ;
Kleiverda, Gunilla .
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2011, 16 (02) :61-66
[25]   Early surgical abortion: Safe and effective [J].
Kara, Fatih ;
Dogan, Nasuh Utku ;
Bati, Serap ;
Demir, Senay ;
Durduran, Yasemin ;
Celik, Cetin .
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2013, 18 (02) :120-126
[26]   Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days [J].
Fjerstad, Mary ;
Sivin, Irving ;
Lichtenberg, E. Steve ;
Trussell, James ;
Cleland, Kelly ;
Cullins, Vanessa .
CONTRACEPTION, 2009, 80 (03) :282-286
[27]   Early medical abortion - available and safe [J].
de Costa, Caroline M. ;
Carrette, Michael .
MEDICAL JOURNAL OF AUSTRALIA, 2012, 197 (05) :257-258
[28]   Medical treatment of miscarriage in a district general hospital is safe and effective up to 12 weeks' gestation [J].
Greenland, H ;
Ogunbiyi, I ;
Bugg, G ;
Tasker, M .
CURRENT MEDICAL RESEARCH AND OPINION, 2003, 19 (08) :699-701
[29]   Comparison of 400 mcg buccal and 400 mcg sublingual misoprostol after mifepristone medical abortion through 63 days' LMP a randomized controlled trial [J].
Raghavan, Sheila ;
Comendant, Rodica ;
Digol, Irena ;
Ungureanu, Sergiu ;
Dondiuc, Iurie ;
Turcanu, Steliana ;
Winikoff, Beverly .
CONTRACEPTION, 2010, 82 (06) :513-519
[30]   Towards safe abortion access: an exploratory study of medical abortion in Cambodia [J].
Petitet, Pascale Hancart ;
Ith, Leakhena ;
Cockroft, Melissa ;
Delvaux, Therese .
REPRODUCTIVE HEALTH MATTERS, 2015, 22 (44) :47-55